161 related articles for article (PubMed ID: 25058639)
1. Cellular changes in blood indicate severe respiratory disease during influenza infections in mice.
Dengler L; Kühn N; Shin DL; Hatesuer B; Schughart K; Wilk E
PLoS One; 2014; 9(7):e103149. PubMed ID: 25058639
[TBL] [Abstract][Full Text] [Related]
2. Hematological parameters in the early phase of influenza A virus infection in differentially susceptible inbred mouse strains.
Preusse M; Schughart K; Wilk E; Klawonn F; Pessler F
BMC Res Notes; 2015 Jun; 8():225. PubMed ID: 26047817
[TBL] [Abstract][Full Text] [Related]
3. Immunization with live virus vaccine protects highly susceptible DBA/2J mice from lethal influenza A H1N1 infection.
Dengler L; May M; Wilk E; Bahgat MM; Schughart K
Virol J; 2012 Sep; 9():212. PubMed ID: 22992381
[TBL] [Abstract][Full Text] [Related]
4. Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection.
Alberts R; Srivastava B; Wu H; Viegas N; Geffers R; Klawonn F; Novoselova N; do Valle TZ; Panthier JJ; Schughart K
Microbes Infect; 2010 Apr; 12(4):309-18. PubMed ID: 20114087
[TBL] [Abstract][Full Text] [Related]
5. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models.
Otte A; Sauter M; Alleva L; Baumgarte S; Klingel K; Gabriel G
Am J Pathol; 2011 Jul; 179(1):230-9. PubMed ID: 21703405
[TBL] [Abstract][Full Text] [Related]
6. Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner.
Nedelko T; Kollmus H; Klawonn F; Spijker S; Lu L; Heßman M; Alberts R; Williams RW; Schughart K
BMC Genomics; 2012 Aug; 13():411. PubMed ID: 22905720
[TBL] [Abstract][Full Text] [Related]
7. Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response.
Meunier I; Morisseau O; Garneau É; Marois I; Cloutier A; Richter MV
PLoS One; 2015; 10(9):e0138055. PubMed ID: 26381265
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.
Bahgat MM; Błazejewska P; Schughart K
Virol J; 2011 Jan; 8():27. PubMed ID: 21251300
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factors.
Blazejewska P; Koscinski L; Viegas N; Anhlan D; Ludwig S; Schughart K
Virology; 2011 Mar; 412(1):36-45. PubMed ID: 21256531
[TBL] [Abstract][Full Text] [Related]
10. Hyporeactivity of Alveolar Macrophages and Higher Respiratory Cell Permissivity Characterize DBA/2J Mice Infected by Influenza A Virus.
Casanova T; Van de Paar E; Desmecht D; Garigliany MM
J Interferon Cytokine Res; 2015 Oct; 35(10):808-20. PubMed ID: 26134384
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.
Vollmer AH; Gebre MS; Barnard DL
Antiviral Res; 2016 Sep; 133():196-207. PubMed ID: 27523492
[TBL] [Abstract][Full Text] [Related]
12. Infection- and procedure-dependent effects on pulmonary gene expression in the early phase of influenza A virus infection in mice.
Preusse M; Tantawy MA; Klawonn F; Schughart K; Pessler F
BMC Microbiol; 2013 Dec; 13():293. PubMed ID: 24341411
[TBL] [Abstract][Full Text] [Related]
13. Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background.
Shin DL; Hatesuer B; Bergmann S; Nedelko T; Schughart K
J Virol; 2015 Oct; 89(19):9998-10009. PubMed ID: 26202236
[TBL] [Abstract][Full Text] [Related]
14. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
Paquette SG; Banner D; Zhao Z; Fang Y; Huang SS; Leόn AJ; Ng DC; Almansa R; Martin-Loeches I; Ramirez P; Socias L; Loza A; Blanco J; Sansonetti P; Rello J; Andaluz D; Shum B; Rubino S; de Lejarazu RO; Tran D; Delogu G; Fadda G; Krajden S; Rubin BB; Bermejo-Martin JF; Kelvin AA; Kelvin DJ
PLoS One; 2012; 7(6):e38214. PubMed ID: 22679491
[TBL] [Abstract][Full Text] [Related]
16. Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ.
Liu B; Zhang X; Deng W; Liu J; Li H; Wen M; Bao L; Qu J; Liu Y; Li F; An Y; Qin C; Cao B; Wang C
Cell Death Dis; 2014 Oct; 5(10):e1440. PubMed ID: 25275588
[TBL] [Abstract][Full Text] [Related]
17. Influenza A (H1N1) virus infection triggers severe pulmonary inflammation in lupus-prone mice following viral clearance.
Slight-Webb SR; Bagavant H; Crowe SR; James JA
J Autoimmun; 2015 Feb; 57():66-76. PubMed ID: 25563403
[TBL] [Abstract][Full Text] [Related]
18. Host genetic background strongly influences the response to influenza a virus infections.
Srivastava B; Błazejewska P; Hessmann M; Bruder D; Geffers R; Mauel S; Gruber AD; Schughart K
PLoS One; 2009; 4(3):e4857. PubMed ID: 19293935
[TBL] [Abstract][Full Text] [Related]
19. Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model.
Lee YH; Lai CL; Hsieh SH; Shieh CC; Huang LM; Wu-Hsieh BA
Virus Res; 2013 Dec; 178(2):411-22. PubMed ID: 24055463
[TBL] [Abstract][Full Text] [Related]
20. Protective memory responses are modulated by priming events prior to challenge.
Rutigliano JA; Morris MY; Yue W; Keating R; Webby RJ; Thomas PG; Doherty PC
J Virol; 2010 Jan; 84(2):1047-56. PubMed ID: 19889782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
